Thomas Struengmann was born in Tegernsee, Germany, Germany. In 2005, Thomas Struengmann and his twin brother, Andreas, who together founded generic drug maker Hexal AG in 1986, sold the business (along with their 68% stake in U.S.-based Eon Labs) to Novartis for $7.5 billion. Since then, they've been actively investing in biotechnology and pharmaceutical companies. Their holdings also include a private bank, Stuttgart-based Sudwestbank. In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann. After obtaining a business degree from the University of Augsburg, Thomas worked as a marketing manager for the U.S. pharmaceutical company Schering-Plough. Like his brother, he is said to be an accomplished golfer and likes to ski. He reportedly collects modern art and Swiss watches.
Thomas Struengmann is a member of Health care
